文献速递主动脉外科

慢性B型主动脉夹层TEVAR术后重塑、再干预与生存

Remodeling, Reintervention, and Survival After Endovascular Repair of Chronic Type B Dissection.
PubMed 文献 · Ann Thorac Surg · 2020-09-20

回顾95例2005至2017年因慢性B型主动脉夹层合并胸主动脉瘤行TEVAR的患者,用三维中心线分析胸腹主动脉解剖表型。早期反向主动脉重塑(RAR,最大胸主动脉直径缩小≥5 mm)发生率41%,与再干预减少相关,但未影响总体生存;再干预率39%。

要点

  • TEVAR治疗慢性B型夹层再干预率高(39%),需严密影像随访。
  • 早期RAR(胸主动脉直径缩小≥5 mm)与1年和3年免于再干预率更高相关。
  • RAR与再干预均未显示影响总体生存。

核心结论

  • 早期反向主动脉重塑与再干预率降低相关,但总体生存未受这些解剖变化影响。
  • 慢性B型夹层TEVAR后再干预率高,需要严格的监测方案。

研究设计与样本

  • 回顾性队列研究,纳入2005至2017年95例因慢性B型主动脉夹层合并胸主动脉瘤接受TEVAR的患者。
  • 采用三维中心线分析对胸腹主动脉进行解剖表型分析。

主要发现

  • 内脏段夹层累及89%(n=85),术前平均胸主动脉直径为63 mm(SD,10)。
  • 6个月内胸主动脉假腔完全血栓形成占71%(n=67),腹部假腔血栓形成占60%(n=57);RAR发生率为41%。
  • 主动脉再干预率为39%(n=37);早期RAR者1年和3年免于再干预率显著更高(log-rank P = .02),但再干预未影响总体生存(log-rank P = .9)。
  • 有无RAR患者的总体生存相似(log-rank P = .4)。

关键数值与推荐

  • RAR定义为最大胸主动脉直径缩小≥5 mm。
  • 胸主动脉直径测量:术前平均63 mm(SD,10)。

临床怎么用

  • TEVAR术后应加强影像学监测以早期发现需再干预的解剖变化。
  • 早期RAR可作为再干预风险较低的影像标志,但不据此判断生存获益。

局限性

  • 为单中心回顾性研究,样本量95例,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The efficacy of thoracic endovascular aortic repair (TEVAR) of chronic type B aortic dissection (cTBAD) is controversial. Only limited evidence describes temporal anatomic changes after TEVAR for cTBAD and their relationship to outcomes. We sought to investigate early aortic remodeling events after TEVAR for cTBAD with thoracic aneurysm and determine the association with reintervention and survival. METHODS: Records from 95 cTBAD patients undergoing TEVAR from 2005 to 2017 were reviewed. Using 3-dimensional centerline analysis, anatomic phenotyping of the thoracoabdominal aorta was performed. Reverse aortic remodeling (RAR) was defined by a ≥5-mm reduction in maximal thoracic aortic diameter. Kaplan-Meier analysis estimated freedom from reintervention and survival. RESULTS: Visceral segment dissection involvement was present in 89% of patients (n = 85), and the mean preoperative thoracic diameter was 63 mm (SD, 10). Complete thoracic false lumen thrombosis occurred in 71% of patients (n = 67), whereas abdominal false lumen thrombosis was documented in 60% (n = 57) by 6 months. RAR occurred in 41%. Aortic reintervention rate was 39% (n = 37). The 1- and 3-year freedom from reintervention was significantly higher in subjects experiencing early RAR (log-rank P = .02), but reintervention did not impact overall survival (log-rank P = .9). Similarly, overall survival was similar between patients with or without RAR (log-rank P = .4). CONCLUSIONS: Early RAR is associated with decreased rates of reintervention; however, overall survival is not impacted by these changes. TEVAR for cTBAD results in a high rate of reintervention, which mandates vigilant surveillance protocols.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Arnaoutakis DJ, Khan TA, Scali ST, et al. Remodeling, Reintervention, and Survival After Endovascular Repair of Chronic Type B Dissection. Ann Thorac Surg. 2020. PMID: 32961141. doi:10.1016/j.athoracsur.2020.07.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。